Additionally, ATAD2 positively regulates KIF4A; their co-expression fosters malignant progression, and aspirin can inhibit ESCC cell phenotypes by downregulating the ATAD2/KIF4A axis [83]. This evidence concerns the gene ATAD2 and esophageal squamous cell carcinoma.